Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017-Reference-Cited by-同舟云学术

Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017

Published:2018-01-18 Issue:3 Volume:23 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Albinsson Bo¹²,Vene Sirkka³²,Rombo Lars⁴⁵,Blomberg Jonas⁶²,Lundkvist Åke²,Rönnberg Bengt¹²

Affiliation:

1. Laboratory of Clinical Microbiology, Uppsala University Hospital, Uppsala, Sweden

2. Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden

3. The Public Health Agency of Sweden, Solna, Stockholm, Sweden

4. Clinical Research Centre, Sormland county council, Uppsala University, Uppsala, Sweden

5. Department of Infectious diseases, Eskilstuna, Sweden

6. Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Abstract

Tick-borne encephalitis virus (TBEV) is an important European vaccine-preventable pathogen. Discrimination of vaccine-induced antibodies from those elicited by infection is important. We studied anti-TBEV IgM/IgG responses, including avidity and neutralisation, by multiplex serology in 50 TBEV patients and 50 TBEV vaccinees. Infection induced antibodies reactive to both whole virus (WV) and non-structural protein 1 (NS1) in 48 clinical cases, whereas 47 TBEV vaccinees had WV, but not NS1 antibodies, enabling efficient discrimination of infection/vaccination.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference10 articles.

1. Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections.;Rönnberg;Med Microbiol Immunol (Berl),2017

2. A rapid fluorescent focus inhibition test for detection of neutralizing antibodies to tick-borne encephalitis virus.;Vene;J Virol Methods,1998

3. Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study.;Hertzell;Vaccine,2016

4. Tick-borne encephalitis.;Lindquist;Lancet,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A serosurvey examining exposure to Borrelia burgdorferi sensu lato and tick-borne encephalitis virus in Danish blood donors, August 2022;IJID Regions;2024-09

2. Development and validation of a novel enzyme-linked immunosorbent assay for the differentiation of tick-borne encephalitis infections caused by different virus subtypes;Infection;2024-08-23

3. Differentiation between mpox infection and MVA immunization by a novel machine learning-supported serological multiplex assay;2024-08-09

4. Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins;npj Vaccines;2024-08-07

5. Global Seroprevalence of Tick-Borne Encephalitis Antibodies in Humans, 1956–2022: A Literature Review and Meta-Analysis;Vaccines;2024-07-30